BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29090070)

  • 21. OCT4 spliced variants are highly expressed in brain cancer tissues and inhibition of OCT4B1 causes G2/M arrest in brain cancer cells.
    Asadi MH; Khalifeh K; Mowla SJ
    J Neurooncol; 2016 Dec; 130(3):455-463. PubMed ID: 27585657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel variant of OCT4B4 is differentially expressed in human embryonic stem and embryonic carcinoma cells.
    Poursani EM; Mehravar M; Soltani BM; Mowla SJ
    Gene; 2017 Sep; 627():369-372. PubMed ID: 28633916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. OCT4B1, a novel spliced variant of OCT4, generates a stable truncated protein with a potential role in stress response.
    Farashahi Yazd E; Rafiee MR; Soleimani M; Tavallaei M; Salmani MK; Mowla SJ
    Cancer Lett; 2011 Oct; 309(2):170-5. PubMed ID: 21684074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. OCT4B-190 protects against ischemic stroke by modulating GSK-3β/HDAC6.
    Chen Y; Wu Z; Zhu X; Zhang M; Zang X; Li X; Xu Y
    Exp Neurol; 2019 Jun; 316():52-62. PubMed ID: 30981804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conclusive Evidence for OCT4 Transcription in Human Cancer Cell Lines: Possible Role of a Small OCT4-Positive Cancer Cell Population.
    Miyamoto T; Mizuno N; Kosaka M; Fujitani Y; Ohno E; Ohtsuka A
    Stem Cells; 2018 Sep; 36(9):1341-1354. PubMed ID: 29770522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA methylation of the Oct4A enhancers in embryonal carcinoma cells after etoposide treatment is associated with alternative splicing and altered pluripotency in reversibly senescent cells.
    Baryshev M; Inashkina I; Salmina K; Huna A; Jackson TR; Erenpreisa J
    Cell Cycle; 2018; 17(3):362-366. PubMed ID: 29372665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of Human Stem Cell Transcription Factors.
    Sneha S; Nagare RP; Manasa P; Vasudevan S; Shabna A; Ganesan TS
    Cell Reprogram; 2019 Aug; 21(4):171-180. PubMed ID: 31298562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revisiting OCT4 expression in peripheral blood mononuclear cells.
    Kotoula V; Papamichos SI; Lambropoulos AF
    Stem Cells; 2008 Jan; 26(1):290-1. PubMed ID: 17932416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostication of OCT4 isoform expression in prostate cancer.
    de Resende MF; Chinen LT; Vieira S; Jampietro J; da Fonseca FP; Vassallo J; Campos LC; Guimarães GC; Soares FA; Rocha RM
    Tumour Biol; 2013 Oct; 34(5):2665-73. PubMed ID: 23636800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deregulation of Stemness-Related Genes in Endometriotic Mesenchymal Stem Cells: Further Evidence for Self-Renewal/Differentiation Imbalance.
    Mashayekhi P; Noruzinia M; Khodaverdi S
    Iran Biomed J; 2020 Sep; 24(5):333-9. PubMed ID: 32429647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Overview on the Complexity of OCT4: at the Level of DNA, RNA and Protein.
    Mehravar M; Ghaemimanesh F; Poursani EM
    Stem Cell Rev Rep; 2021 Aug; 17(4):1121-1136. PubMed ID: 33389631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ectopic expression of OCT4B1 Decreases Fertility Rate and Changes Sperm Parameters in Transgenic Mice.
    Naseri M; Ranaei Pirmardan E; Mowla SJ; Shamsara M; Movahedin M; Nouri S; Nayernia K; Kabir Salmani M; Shahali M
    Iran J Biotechnol; 2022 Jul; 20(3):e3019. PubMed ID: 36381279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The differential expression of OCT4 isoforms in cervical carcinoma.
    Li SW; Wu XL; Dong CL; Xie XY; Wu JF; Zhang X
    PLoS One; 2015; 10(3):e0118033. PubMed ID: 25816351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. OCT4B1 isoform: the novel OCT4 alternative spliced variant as a putative marker of stemness.
    Papamichos SI; Kotoula V; Tarlatzis BC; Agorastos T; Papazisis K; Lambropoulos AF
    Mol Hum Reprod; 2009 May; 15(5):269-70. PubMed ID: 19258399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OCT4B mediates hypoxia-induced cancer dissemination.
    Lin SC; Chung CH; Chung CH; Kuo MH; Hsieh CH; Chiu YF; Shieh YS; Chou YT; Wu CW
    Oncogene; 2019 Feb; 38(7):1093-1105. PubMed ID: 30209362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic expression alteration analysis of master reprogramming factor OCT4 and its three pseudogenes in human cancer and their prognostic outcomes.
    Saha SK; Jeong Y; Cho S; Cho SG
    Sci Rep; 2018 Oct; 8(1):14806. PubMed ID: 30287838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of
    Turyova E; Mikolajcik P; Grendar M; Kudelova E; Holubekova V; Kalman M; Marcinek J; Hrnciar M; Kovac M; Miklusica J; Laca L; Lasabova Z
    Front Oncol; 2023; 13():1166835. PubMed ID: 37409260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OCT4B1 Regulates the Cellular Stress Response of Human Dental Pulp Cells with Inflammation.
    Liu L; Huang R; Yang R; Wei X
    Biomed Res Int; 2017; 2017():2756891. PubMed ID: 28473980
    [No Abstract]   [Full Text] [Related]  

  • 39. Rat growth hormone receptor/growth hormone-binding protein mRNAs with divergent 5'-untranslated regions are expressed in a tissue-specific manner.
    Domené HM; Cassorla F; Werner H; Roberts CT; Leroith D
    DNA Cell Biol; 1995 Mar; 14(3):195-204. PubMed ID: 7880440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spatiotemporal dynamics of OCT4 protein localization during preimplantation development in mice.
    Fukuda A; Mitani A; Miyashita T; Kobayashi H; Umezawa A; Akutsu H
    Reproduction; 2016 Nov; 152(5):417-30. PubMed ID: 27495230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.